Eb306 Nasal Decongestant
NDC Package 53304-0306-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Eb306 Nasal Decongestant is a medication used as Nasal Decongestant. Marketed by Eminence Biotech Corporation Limited, this product is identified by NDC 53304-0306 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
53304-0306-1
Package Description
1 BOTTLE, SPRAY in 1 BOX / 15 mL in 1 BOTTLE, SPRAY
Product Code
53304-0306
11-Digit Billing Format
53304030601
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Eb306 Nasal Decongestant
Dosage Form
-
Usage Information
This product is used as Nasal Decongestant. For the temporary relief of nasal congestion due to hay fever or other upper respiratory allergies (allergic rhinitis)

Regulatory & Marketing

Labeler Name
Eminence Biotech Corporation Limited
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
11-01-2012
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53304-0306-1 identifies a specific commercial package of 1 bottle, spray in 1 box / 15 ml in 1 bottle, spray of Eb306 Nasal Decongestant, labeled by Eminence Biotech Corporation Limited. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Eminence Biotech Corporation Limited on November 01, 2012. The current certification is valid through December 31, 2022.

How is this Eminence Biotech Corporation Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53304030601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
53304-0306-1
11-Digit CMS (5-4-2)
53304-0306-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.